Table 1.
The distribution of covariates, divided by mental disorder or not before the study period.
Mental disorder |
No mental disorder |
Cohen's ha | |||
---|---|---|---|---|---|
N | % | N | % | ||
Sex (% men) | 68,793 | 35 | 670,330 | 51 | −0.32 |
Age group | |||||
18–49 | 108,285 | 55 | 654,894 | 50 | |
50–69 | 60,861 | 31 | 427,259 | 32 | |
70+ | 26,419 | 14 | 238,552 | 18 | |
Living in care home | 3484 | 2 | 12,946 | 1 | |
Country of birth | |||||
Sweden | 148,426 | 76 | 947,430 | 72 | |
Other Nordic countries | 6320 | 3 | 44,959 | 3 | |
Middle East | 11,260 | 6 | 72,233 | 5 | |
South Europe | 5807 | 3 | 45,961 | 3 | |
North and East Africa | 3374 | 2 | 36,078 | 3 | |
Other OECD countries | 3813 | 2 | 31,627 | 2 | |
Other countries | 16,565 | 8 | 142,417 | 11 | |
Education | |||||
≤9 yrs | 27,256 | 14 | 162,641 | 12 | |
10–12 yrs | 75,832 | 39 | 484,313 | 37 | |
>12 yrs | 92,477 | 47 | 673,751 | 51 | |
Income, quintiles | |||||
Lowest | 48,861 | 25 | 219,304 | 17 | 0.20 |
2nd | 45,968 | 24 | 254,411 | 19 | |
3rd | 40,088 | 20 | 265,103 | 20 | |
4th | 34,351 | 18 | 281,803 | 21 | |
Highest | 26,297 | 13 | 300,084 | 23 | −0.26 |
Socioeconomically vulnerable area | 16,882 | 9 | 102,562 | 8 | |
Proportion with inpatient COVID-19 diagnosis in area, quintiles | |||||
Lowest | 36,665 | 19 | 260,276 | 20 | |
2nd | 37,251 | 19 | 266,258 | 20 | |
3rd | 44,022 | 23 | 281,952 | 21 | |
4th | 39,296 | 20 | 258,752 | 20 | |
Highest | 38,331 | 20 | 253,467 | 19 | |
Household size | |||||
1 | 60,853 | 31 | 285,839 | 22 | 0.20 |
2 | 56,359 | 29 | 425,768 | 32 | |
3 | 31,592 | 16 | 216,016 | 16 | |
4 | 28,663 | 15 | 233,734 | 18 | |
5 | 11,287 | 6 | 93,989 | 7 | |
6+ | 6811 | 3 | 65,359 | 5 | |
Crowded housing | 26,116 | 13 | 196,543 | 15 | |
Job exposure | |||||
No occupation | 71,761 | 37 | 434,540 | 33 | |
Work from home >50% | 58,954 | 30 | 461,132 | 35 | |
Work from home <50% | 47,393 | 24 | 331,063 | 25 | |
Work from home <50%, healthcare | 17,457 | 9 | 93,970 | 7 | |
Healthcare visits, outside home | |||||
0 | 32,818 | 17 | 545,827 | 41 | −0.54 |
1–5 | 78,314 | 40 | 532,510 | 40 | |
>5 | 84,433 | 43 | 242,368 | 18 | 0.55 |
Healthcare visits, in home | |||||
0 | 179,614 | 92 | 1,263,218 | 96 | |
1–5 | 8627 | 4 | 32,848 | 2 | |
>5 | 7324 | 4 | 24,639 | 2 | |
Somatic disorders | |||||
Obesity | 13,409 | 7 | 43,065 | 3 | |
CVD | 9390 | 5 | 57,682 | 4 | |
Cancer | 10,531 | 5 | 73,819 | 6 | |
Diabetes | 15,217 | 8 | 87,031 | 7 | |
COPD | 7248 | 4 | 25,863 | 2 | |
Kidney | 5081 | 3 | 28,732 | 2 | |
Psychotropics | |||||
Benzodiazepines | 50,286 | 26 | 91,000 | 7 | 0.53 |
Atypical neuroleptics | 17,776 | 9 | 6046 | 0,5 | 0.47 |
Cohen's h = Standardized difference of proportions. Cohen's h > 0.20 indicates small effect size, >0.50 moderate effect size, >0.80 large effect size (Cohen, 1988).
Cohen's h < 0.20 were omitted from the table.